Dermatologicals in New Zealand

Dermatologicals in New Zealand

Dermatologicals is set to maintain retail current value growth in New Zealand in 2024. With higher costs being passed on to consumers, value growth within the category has been strongly influenced by unit price increases, with the rate of value growth high than volume growth in this year. However, with price disruption starting to ease, and New Zealand having entered a recession in 2023, unit price growth is expected to stabilise moving forward.

Euromonitor International's Dermatologicals in New Zealand report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2019-2023, allowing you to identify the sectors driving growth. Forecasts to 2028 illustrate how the market is set to change.

Product coverage: Antiparasitics/Lice (Head and Body) Treatments, Antipruritics, Cold Sore Treatments, Haemorrhoid Treatments, Hair Loss Treatments, Medicated Shampoos, Nappy (Diaper) Rash Treatments, Paediatric Dermatologicals, Topical Allergy Remedies/Antihistamines, Topical Antifungals, Topical Germicidals/Antiseptics, Vaginal Antifungals.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
* Get a detailed picture of the Dermatologicals market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.